3Bar Biologics Secures $2M to Help Farmers Increase Crop Yields with Naturally Occurring Microbes

Investors include Rev1 Ventures, Maumee Ventures, Ohio TechAngel Funds and SVG Thrive Fund— Columbus, OH, August 16, 2017—Today, 3Bar Biologics Inc., the provider of a beneficial microbe delivery system, announced it has secured $2M in funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio TechAngel Funds, Queen City Angels, Carmen Innovations, and SVG […]

3Bar Awarded SBIR Phase II from USDA

Rev1 Portfolio Company Receives SBIR R&D Capital: 3Bar Biologics— Columbus, Ohio, August 10, 2017 —3Bar Biologics, a spinout from The Ohio State University, was awarded a $100,000 Phase I SBIR from the Department of Agriculture (USDA). We tend to ring bells and shoot-off fireworks when major funding events with angels and venture capitalists occur. We […]